Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a...
Q1 2026
May 20, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 13, 2025